Anne Tuggle, MD
Family Medicine · Mauldin, SCNPI 1518923531
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,506 of the $13,693 with a category attached, or 76.7%. It is spread thinly across 36 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,333 and has fallen 85.5% since, to $483 in 2025. Among family medicine clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 419 payments — averaging $32.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$2K
- Genentech USA, Inc.$2K
- AstraZeneca$2K
- GSK$1K
- AbbVie$1K
- Johnson & Johnson$1K
- plus $5K from 30 others
Across 55 payments — averaging $39,371 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2.1M
- AstraZeneca$41K
- Chiesi USA, Inc.$31K
- Genentech, Inc.$21K
What the payments were for
- Speaking & faculty fees$701%
- Travel & lodging$3,11223%
- Food & beverage$10,50677%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 17 | $2,001 |
| Genentech USA, Inc. | 6 | $1,781 |
| AstraZeneca | 38 | $1,718 |
| GSK | 41 | $1,229 |
| AbbVie(2 entities) | 72 | $1,118 |
| Johnson & Johnson | 35 | $1,106 |
| Novo Nordisk | 28 | $806 |
| Daiichi Sankyo Inc. | 18 | $622 |
| Pfizer | 31 | $621 |
| Bayer | 23 | $513 |
| Lilly USA, LLC | 20 | $324 |
| Amgen | 9 | $311 |
| Sanofi-aventis U.S. LLC | 11 | $169 |
| Biohaven Pharmaceuticals, Inc. | 2 | $146 |
| Boehringer Ingelheim | 9 | $134 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $129 |
| Medtronic(2 entities) | 2 | $124 |
| Eisai Inc. | 6 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $85 |
| Abbott | 4 | $81 |
| Merck | 5 | $77 |
| Sanofi | 1 | $70 |
| Sunovion Pharmaceuticals Inc. | 6 | $64 |
| Esperion Therapeutics, Inc. | 4 | $60 |
| Amarin Pharma, Inc. | 3 | $56 |
| Astellas Pharma US Inc | 3 | $46 |
| Edwards Lifesciences | 1 | $30 |
| Exact Sciences | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $27 |
| Philips North America LLC | 1 | $23 |
| Adlon Therapeutics L.p. | 1 | $20 |
| Novartis | 1 | $17 |
| Gilead | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Corcept Therapeutics | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,693 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $53,291 |
| OzempicSemaglutide | 31 | $52,568 |
| JardianceEmpagliflozin | 31 | $39,271 |
| TrulicityDulaglutide | 23 | $29,036 |
| FarxigaDapagliflozin Propanediol | 14 | $23,747 |
| RybelsusSemaglutide | 17 | $23,261 |
| MyrbetriqMirabegron | 23 | $19,445 |
| EliquisApixaban | 25 | $18,731 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 20 | $6,404 |
| Xigduo XrDapaglifloz Propaned/Metformin | 15 | $6,122 |
| VascepaIcosapent Ethyl | 12 | $6,003 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $3,342 |
| Rosuvastatin Calcium | 184 | $2,871 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 24 | $2,066 |
| Atorvastatin Calcium | 176 | $1,931 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $806 | $75,82948 claims |
| GSKTrelegy Ellipta | $1,229 | $53,29135 claims |
| Boehringer IngelheimJardiance | $134 | $39,27131 claims |
| Lilly USA, LLCTrulicity | $324 | $29,03623 claims |
| PfizerEliquis, Abrysvo | $621 | $25,13545 claims |
| AstraZenecaFarxiga | $1,718 | $23,74714 claims |
| Astellas Pharma US IncMyrbetriq | $46 | $19,44523 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Mauldin
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
- Ada StewartColumbia$186K
- Jeffrey BroderNorth Augusta$140K
- Terry NagelColumbia$112K
- Katherine JohnsonGreenwood$80K
- Scott SmithMount Pleasant$68K
- Jennifer StolinSummerville$59K
- Nicholas PenningsNorth Myrtle Beach$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.